Key result
Pharmacological and electrical cardioversion manage AF during pregnancy to prevent recurrence and stroke.
Why the study?
Atrial fibrillation during pregnancy is rare and few studies have discussed its proper management.
What is the proper management of atrial fibrillation during pregnancy using pharmacological and electrical cardioversion?
What is the proper management of atrial fibrillation during pregnancy using pharmacological and electrical cardioversion?
This review highlights the management of atrial fibrillation during pregnancy using pharmacological and electrical cardioversion.
Answers are grounded in this paper and cite their sources.
Cardioversion options may be considered for AF in pregnancy; leaves open need for prospective data on safety and outcomes.
Atrial fibrillation during pregnancy is a rare condition and often occurs in patients with underlying heart disease. The management of AF during pregnancy includes both electrical and pharmacological cardioversion to prevent recurrence and stroke. In recent years, few studies have been discussed the proper management of AF in pregnancy. This literature highlights both pharmacological and electrical cardioversion of atrial fibrillation during pregnancy.
No takes yet. Share an insight, caveat, or question.
Djakpo et al. (2019) conducted a review in Atrial fibrillation during pregnancy. Pharmacological and electrical cardioversion was evaluated. This review highlights both pharmacological and electrical cardioversion as management strategies to prevent recurrence and stroke in patients with atrial fibrillation during pregnancy.
Synapse has enriched 10 related papers. Consider them for comparative context: